ArticleCureus2023

Feasibility of Using Ceftazidime-Avibactam as a Therapeutic Option for Bloodstream Infections Caused by Multidrug-Resistant Enterobacterales and Pseudomonas aeruginosa Based on Its Susceptibility Profile.

Ketan Priyadarshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.